Rare diseases
Investigational molecules
Locations
Study of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma
AustriaStudy on the Effects of Amlitelimab for Adults with Non-Responsive Celiac Disease
BelgiumStudy of Different Doses of Amlitelimab Given by Injection Under the Skin in Adults with Moderate to Severe Asthma
HungaryStudy on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
FranceStudy on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
BulgariaStudy on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials
BulgariaStudy of amlitelimab injection compared to placebo for adults with severe alopecia areata (hair loss)
BulgariaStudy on Amlitelimab for Adults with Moderate to Severe Hidradenitis Suppurativa
FranceStudy on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
BulgariaStudy on Amlitelimab for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis Using Topical Corticosteroids and Inadequate Response to Previous Treatments
FranceStudy on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis Using Topical Corticosteroids
BulgariaStudy on the Long-Term Safety and Effectiveness of Amlitelimab for Adults with Moderate to Severe Atopic Dermatitis
CzechiaTell us about your condition – we search every trial in Europe and connect you with the right site.
